Elsevier,
Behavioural Brain Research, Volume 471, 5 August 2024
This review discusses the impact of Apolipoprotein-E4 (ApoE4) on cognitive performance in targeted-replacement human ApoE knock-in mice, finding that ApoE4 mice exhibit significant cognitive deficits compared to ApoE3 mice in various cognitive tests, indicating an intrinsic vulnerability in ApoE4 mice that may be exacerbated in the context of neurodegenerative diseases.
Elsevier,
Journal of Climate Change and Health, Volume 18, 1 July 2024
Indigenous Peoples face disproportionate risks from climate change while being key to planetary health and climate resilience due to their traditional ecological knowledge. This manuscript provides Indigenous perspectives on climate justice, exploring the intersection of health, sovereignty, and ancestral practices, and discusses opportunities for decolonizing relationships to place, highlighting a case of rematriation and healing at Bdóte, the place of genesis for Dakota Peoples, also known as Minneapolis and Saint Paul, MN.
Elsevier,
Heliyon, Volume 10, 15 July 2024
This knowledge encompasses information about the local environment, including farming patterns, soil types, weather patterns, and other natural resources. Such indigenous agricultural practices are valuable methods, and these communities have illustrated the effectiveness, adaptability, and ways in which these adopted methods promote sustainable environmental management.
Elsevier,
Engineering Applications of Artificial Intelligence, Volume 133, July 2024
With evident relevance to SDG 6, the research explores a water pollution control technology evaluation model based on the Pythagorean language neutrosophic set (PLNS) in the context of the pulp and paper industry. The authors' model aims to assist in the choice of appropriate water pollution control technology for those working within the paper industry. It is tested in an example based in China.
Elsevier,
Acta Pharmaceutica Sinica B, Volume 14, July 2024
The study discusses the latest developments in Alzheimer’s disease treatment, with a focus on monoclonal antibodies and aptamers. It covers the current state of therapies, recent drug approvals, and future perspectives on immunotherapeutic strategies.
Elsevier,
Neuroscience Research, Volume 204, July 2024
This study found that Alzheimer’s disease neuropathological change (ADNC) is associated with gene expression changes that may impair cholesterol biosynthesis in neurones but not astrocytes, whilst levels of cortical cholesterol show a weak relationship to dementia status.
